Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| FLEXION THERAPEUT (NYSE: FLXN) | Delayed: 24.10 -0.03 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.13 | 52 Week High | $23.57 | |||
| Open | $24.07 | 52 Week Low | $7.56 | |||
| Day High | $24.11 | P/E | N/A | |||
| Day Low | $24.04 | EPS | $-2.04 | |||
| Volume | 5,278 | |||||
